[1] Niewerth M, Korting HC. Management of onychomycoses. Drugs, 1999,58:283-296.
[2] Lestringant GG, Nsanze H, Nada M, et al. Effectiveness of amorolfine 5% nail lacquer in the treatment of long duration candida onychomycosis with chronic paronychia. J Dermatol Treatment, 1996,7:89-92.
[3] Cohen PR, Scher RK. Topical and surgical treatment of onychomycosis. J Am Acad Dermatol, 1994,31:S74-S77.
[4] Gupta AK, Sauder DN, Shear NH. Antifungal agents:an overview. Part II. J Am Acad Dermatol, 1994,30:911-933.
[5] Haria M, Bryson HM. Amorolfine a review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections. Drugs, 1995,49:103-120.
[6] Pittrof F, Gerhards J, Erni W,et al. Loceryl nail lacquer realization of a new galenical approach to onychomycosis therapy. Clin Exp Dermatol, 1992,17(Suppl 1):26-28.
[7] Mensing H, Polak A, Splanemann V. Determination of the subungual antifungal activity of amorolfine after 1 month's treatment in patients with onychomycosis:comparison of two nail lacquer formulations. Clin Exp Dermatol, 1992,17(Suppl 1):29-32.
[8] Lauharanta J. Comparative efficacy and safety of amorolfine nail lacquer 2% versus 5% once weekly. Clin Exp Dermatol, 1992,17(Suppl 1):41-43.
[9] Reinel D. Topical treatment of onychomycosis with amorolfine 5% nail lacquer:comparative efficacy and tolerability of once and twice weekly use. Dermatol,1992,184(Suppl 1):21-24.
[10] Reinel D, Clarke C. Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis,once weekly versus twice
[11] weekly. Clin Exp Dermatol, 1992,17(Suppl 1):44-49.
[12] Kwok YK, Tay YK, Goh CL, et al. Epidemiology and in vitro activity of antimycotics against candidal vaginal/skin/nail infections in singapore. Int J Dermatol, 1998,37:145-149.
[13] Polak A. Combination of amorolfine with various antifungal drugs in dermatophytosis. Mycoses, 1993,36:43-49.
[14] Lauharanta J,Zauf M,Polak A,et al. Combination of amorolfine with griseofulvin:in vitro activity and clinical results in onychomycosis. JAMA SEA, 1993,(Suppl):23-27.
[15] Baran R,Feuilhade M,Datry A,et al. A randomized trail of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region. Br J Dermatol, 2000,142:1177-1183. |
